Specifically, FGF23 is associated with left ventricular hypertrophy (LVH) [19–21], impaired left ventricular function [19], endothelial dysfunction [22, 23], heart failure [24] and progression of renal failure [15, 19] in adult CKD. Here, FGF23 is linked to chronic kidney disease.